Vaccine development and safety

Avinash K. Shetty, Yvonne A. Maldonado

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Vaccines are considered one of the most effective public health achievements of the twentieth century. In the USA the incidence of most childhood vaccine-preventable diseases (VPDs) is at historic lows, while the number of diseases prevented by vaccines has increased steadily in the past few years. Development of vaccines is a complex, multistep process requiring the collaboration of multiple partners from basic science research through vaccine delivery and outcome monitoring. Advances in new sciences such as genomics, structural biology, novel adjuvant formulations, live vector vaccines, and computational studies have led to more detailed understanding of microbes and the host immune response. These advances offer great promise in the design of future generation of effective and safe vaccines against a host of infectious diseases. In addition, development of nontraditional vaccines against cancer, autoimmune disorders, and chronic diseases of ageing are currently being explored. Vaccine safety remains an integral component of the US immunization system involving several federal agencies such as the US Food and Drug Administration (FDA), the Centers for Disease Control and Prevention (CDC), and other federal agencies working in close partnerships with vaccine resources in the public and private sectors. Despite significant advances, there are many scientific, implementation, and policy challenges to modern vaccine development. Educating the public about vaccines and vaccine preventable diseases is crucial to improve vaccine acceptance and use. A trusting relationship between patients, parents, and health care providers is a must to effectively communicate vaccine risk-benefit issues.

Original languageEnglish
Title of host publicationVaccinophobia and Vaccine Controversies of the 21st Century
PublisherSpringer New York
Pages15-49
Number of pages35
ISBN (Electronic)9781461474388
ISBN (Print)146147437X, 9781461474371
DOIs
Publication statusPublished - 01-11-2013
Externally publishedYes

Fingerprint

Vaccines
Safety
Cancer Vaccines
Private Sector
Public Sector
Sexual Partners
Social Responsibility
United States Food and Drug Administration
Centers for Disease Control and Prevention (U.S.)
Genomics
Health Personnel
Autoimmune Diseases
Communicable Diseases
Immunization
Patient Care
Chronic Disease
Public Health
Parents
Incidence

All Science Journal Classification (ASJC) codes

  • Nursing(all)

Cite this

Shetty, A. K., & Maldonado, Y. A. (2013). Vaccine development and safety. In Vaccinophobia and Vaccine Controversies of the 21st Century (pp. 15-49). Springer New York. https://doi.org/10.1007/978-1-4614-7438-8_2
Shetty, Avinash K. ; Maldonado, Yvonne A. / Vaccine development and safety. Vaccinophobia and Vaccine Controversies of the 21st Century. Springer New York, 2013. pp. 15-49
@inbook{890e636696374c3e88500b3fb09ebc6c,
title = "Vaccine development and safety",
abstract = "Vaccines are considered one of the most effective public health achievements of the twentieth century. In the USA the incidence of most childhood vaccine-preventable diseases (VPDs) is at historic lows, while the number of diseases prevented by vaccines has increased steadily in the past few years. Development of vaccines is a complex, multistep process requiring the collaboration of multiple partners from basic science research through vaccine delivery and outcome monitoring. Advances in new sciences such as genomics, structural biology, novel adjuvant formulations, live vector vaccines, and computational studies have led to more detailed understanding of microbes and the host immune response. These advances offer great promise in the design of future generation of effective and safe vaccines against a host of infectious diseases. In addition, development of nontraditional vaccines against cancer, autoimmune disorders, and chronic diseases of ageing are currently being explored. Vaccine safety remains an integral component of the US immunization system involving several federal agencies such as the US Food and Drug Administration (FDA), the Centers for Disease Control and Prevention (CDC), and other federal agencies working in close partnerships with vaccine resources in the public and private sectors. Despite significant advances, there are many scientific, implementation, and policy challenges to modern vaccine development. Educating the public about vaccines and vaccine preventable diseases is crucial to improve vaccine acceptance and use. A trusting relationship between patients, parents, and health care providers is a must to effectively communicate vaccine risk-benefit issues.",
author = "Shetty, {Avinash K.} and Maldonado, {Yvonne A.}",
year = "2013",
month = "11",
day = "1",
doi = "10.1007/978-1-4614-7438-8_2",
language = "English",
isbn = "146147437X",
pages = "15--49",
booktitle = "Vaccinophobia and Vaccine Controversies of the 21st Century",
publisher = "Springer New York",
address = "United States",

}

Shetty, AK & Maldonado, YA 2013, Vaccine development and safety. in Vaccinophobia and Vaccine Controversies of the 21st Century. Springer New York, pp. 15-49. https://doi.org/10.1007/978-1-4614-7438-8_2

Vaccine development and safety. / Shetty, Avinash K.; Maldonado, Yvonne A.

Vaccinophobia and Vaccine Controversies of the 21st Century. Springer New York, 2013. p. 15-49.

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - Vaccine development and safety

AU - Shetty, Avinash K.

AU - Maldonado, Yvonne A.

PY - 2013/11/1

Y1 - 2013/11/1

N2 - Vaccines are considered one of the most effective public health achievements of the twentieth century. In the USA the incidence of most childhood vaccine-preventable diseases (VPDs) is at historic lows, while the number of diseases prevented by vaccines has increased steadily in the past few years. Development of vaccines is a complex, multistep process requiring the collaboration of multiple partners from basic science research through vaccine delivery and outcome monitoring. Advances in new sciences such as genomics, structural biology, novel adjuvant formulations, live vector vaccines, and computational studies have led to more detailed understanding of microbes and the host immune response. These advances offer great promise in the design of future generation of effective and safe vaccines against a host of infectious diseases. In addition, development of nontraditional vaccines against cancer, autoimmune disorders, and chronic diseases of ageing are currently being explored. Vaccine safety remains an integral component of the US immunization system involving several federal agencies such as the US Food and Drug Administration (FDA), the Centers for Disease Control and Prevention (CDC), and other federal agencies working in close partnerships with vaccine resources in the public and private sectors. Despite significant advances, there are many scientific, implementation, and policy challenges to modern vaccine development. Educating the public about vaccines and vaccine preventable diseases is crucial to improve vaccine acceptance and use. A trusting relationship between patients, parents, and health care providers is a must to effectively communicate vaccine risk-benefit issues.

AB - Vaccines are considered one of the most effective public health achievements of the twentieth century. In the USA the incidence of most childhood vaccine-preventable diseases (VPDs) is at historic lows, while the number of diseases prevented by vaccines has increased steadily in the past few years. Development of vaccines is a complex, multistep process requiring the collaboration of multiple partners from basic science research through vaccine delivery and outcome monitoring. Advances in new sciences such as genomics, structural biology, novel adjuvant formulations, live vector vaccines, and computational studies have led to more detailed understanding of microbes and the host immune response. These advances offer great promise in the design of future generation of effective and safe vaccines against a host of infectious diseases. In addition, development of nontraditional vaccines against cancer, autoimmune disorders, and chronic diseases of ageing are currently being explored. Vaccine safety remains an integral component of the US immunization system involving several federal agencies such as the US Food and Drug Administration (FDA), the Centers for Disease Control and Prevention (CDC), and other federal agencies working in close partnerships with vaccine resources in the public and private sectors. Despite significant advances, there are many scientific, implementation, and policy challenges to modern vaccine development. Educating the public about vaccines and vaccine preventable diseases is crucial to improve vaccine acceptance and use. A trusting relationship between patients, parents, and health care providers is a must to effectively communicate vaccine risk-benefit issues.

UR - http://www.scopus.com/inward/record.url?scp=84929553809&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929553809&partnerID=8YFLogxK

U2 - 10.1007/978-1-4614-7438-8_2

DO - 10.1007/978-1-4614-7438-8_2

M3 - Chapter

SN - 146147437X

SN - 9781461474371

SP - 15

EP - 49

BT - Vaccinophobia and Vaccine Controversies of the 21st Century

PB - Springer New York

ER -

Shetty AK, Maldonado YA. Vaccine development and safety. In Vaccinophobia and Vaccine Controversies of the 21st Century. Springer New York. 2013. p. 15-49 https://doi.org/10.1007/978-1-4614-7438-8_2